Paper Details
- Home
- Paper Details
[Dynamics of left ventricular longitudinal function in patients with arterial hypertension during therapy with angiotensin converting enzyme inhibitor moexipril].
Author: Bakhmet'evaT A, KarpovR S, PavliukovaE N, PuzyrevK V
Original Abstract of the Article :
AIM: To assess left ventricular longitudinal systolic and diastolic function in patients with arterial hypertension in whom regression of left ventricular (LV) hypertrophy (LVH) occurred at the background of long term therapy with angiotensin converting enzyme inhibitor moexipril and hydrochlorothia...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/17047618
データ提供:米国国立医学図書館(NLM)
Assessing Left Ventricular Longitudinal Function in Hypertensive Patients During Moexipril Therapy
This research investigates the impact of moexipril, an angiotensin-converting enzyme inhibitor (ACEI), on left ventricular (LV) longitudinal function in patients with arterial hypertension. The study involved 44 patients with concentric LV hypertrophy who underwent 12 months of treatment with moexipril and hydrochlorothiazide. The findings revealed that moexipril therapy was associated with a decrease in LV mass and improvements in 24-hour blood pressure monitoring. Furthermore, the study observed positive changes in LV longitudinal systolic and diastolic function, particularly in terms of early LV filling and myocardial relaxation. The authors conclude that moexipril treatment may be effective in reversing LV hypertrophy and improving LV function in patients with arterial hypertension.Understanding the Therapeutic Benefits of Moexipril in Hypertension Management
This research provides valuable insights into the positive effects of moexipril on LV function in hypertensive patients. The study's findings suggest that moexipril therapy can effectively reduce LV mass and improve both systolic and diastolic function. These findings highlight the importance of considering ACEIs as a therapeutic option for managing hypertension and preventing or reversing LV hypertrophy.Managing Cardiovascular Health with Moexipril
This research emphasizes the importance of managing cardiovascular health in individuals with hypertension. The study's findings suggest that moexipril therapy may be beneficial in improving LV function and reducing the risk of heart-related complications. Consult with your physician to discuss potential treatment options and strategies for managing your cardiovascular health.Dr. Camel's Conclusion
This study reminds me of the intricate workings of the heart, like a delicate desert oasis in the vast expanse of our bodies. Moexipril, by promoting relaxation and improving function, helps to maintain the heart's vital role in supporting our overall well-being. This research encourages us to appreciate the remarkable power of medications to address cardiovascular concerns and promote a healthy life.Date :
- Date Completed 2006-10-31
- Date Revised 2017-03-10
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
Russian
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.